the concern I have is that on May 1 they stated that the Teva portfolio was broadly in line with expectations, that being EBITDA of 6 times acquisition price, I have that at $109m.
now today they are forecasting EBITDA on Teva of $94.5m, that seems a very steep drop off in two months?
I'm happy to be corrected, quick calcs on my part.
- Forums
- ASX - By Stock
- MYX
- Fundamentals Are Strong
Fundamentals Are Strong, page-600
-
-
- There are more pages in this discussion • 272 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MYX (ASX) to my watchlist
|
|||||
Last
$4.36 |
Change
-0.160(3.54%) |
Mkt cap ! $370.9M |
Open | High | Low | Value | Volume |
$4.51 | $4.51 | $4.32 | $562.8K | 128.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2150 | $4.35 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.39 | 474 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2150 | 4.350 |
2 | 1134 | 4.340 |
3 | 619 | 4.330 |
2 | 608 | 4.320 |
2 | 608 | 4.310 |
Price($) | Vol. | No. |
---|---|---|
4.390 | 474 | 1 |
4.400 | 474 | 1 |
4.410 | 474 | 1 |
4.420 | 474 | 1 |
4.440 | 9421 | 6 |
Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |